Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Dec;6(6):597-604.
doi: 10.1007/BF00052561.

Effects of calcium channel agonism by Bay-K-8644 on ventricular fibrillation threshold of isolated heart

Affiliations

Effects of calcium channel agonism by Bay-K-8644 on ventricular fibrillation threshold of isolated heart

M G Worthington et al. Cardiovasc Drugs Ther. 1992 Dec.

Abstract

The hypothesis tested was that enhanced entry of calcium into cardiac cells would increase the susceptibility to ventricular fibrillation as measured by the ventricular fibrillation threshold (VFT) of the isolated perfused rat heart. Bay-K-8644 was used as a calcium-channel agonist. There was a biphasic effect with a maximal increase in left ventricular systolic pressure and oxygen uptake at a concentration of 10(-7) M. The same concentration caused a major reduction in the VFT. The bell-shaped pattern of fall of the VFT was inversely related to the effect on LV developed pressure. The changes in VFT could be dissociated from those on myocardial metabolites. Although Bay-K-8644 increased the heart rate, reduction of the VFT could also be obtained in paced hearts. The addition of ryanodine, an agent known to interrupt intracellular recycling of calcium through the sarcoplasmic reticulum, was able to abolish approximately half the effect of Bay-K-8644 on the VFT. Therefore, increased entry of calcium via the calcium channel is able to reduce VFT, acting in part through enhanced recycling of calcium through the sarcoplasmic reticulum.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1988 Aug 5;263(22):10843-50 - PubMed
    1. Ann N Y Acad Sci. 1988;522:464-77 - PubMed
    1. J Mol Cell Cardiol. 1975 Feb;7(2):135-51 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4824-7 - PubMed
    1. Nature. 1984 Jan 26-Feb 1;307(5949):371-5 - PubMed

Publication types

MeSH terms

Substances